☆ 4.5 Article

Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody

IMMUNOLOGY LETTERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19

Fatih Colkesen et al.

Summary: The study aimed to investigate the relationship between B cell-mediated immunity and disease severity and mortality in patients with COVID-19. The results showed that deceased patients had significantly lower levels of B lymphocytes and serum immunoglobulins. These parameters were negatively correlated with COVID-19 severity scores. Decreased B cell numbers and lower serum immunoglobulin levels were independent risk factors for mortality in COVID-19 patients.

POSTGRADUATE MEDICAL JOURNAL (2022)

添加到收藏夹

Review Immunology

Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice

Mehran Ghasemzadeh et al.

Summary: The COVID-19 virus disrupts immune responses by interfering with the cytolytic antiviral effects of NK cells and activating immune cells, leading to a dangerous cytokine storm. Improving the cytotoxicity of NK cells may benefit treatment protocols, and the clonal expansion of activating NK memory cells holds promise for vaccine development and NK cell therapy in COVID-19.

HUMAN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment

Henrry Diaz Londres et al.

Summary: This study evaluated the safety and efficacy of nimotuzumab in COVID-19 patients. The results showed that nimotuzumab is a safe antibody that can reduce inflammation and prevent fibrosis.

IMMUNOTHERAPY (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Major coagulation disorders and parameters in COVID-19 patients

Azadeh Teimury et al.

Summary: COVID-19 infection leads to coagulation and inflammatory problems, such as venous thromboembolism and pulmonary embolism, and affects coagulation markers. Timely treatment and regular examination of coagulation parameters are crucial for patients.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

添加到收藏夹

Review Chemistry, Medicinal

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

Choongho Lee et al.

Summary: The novel coronavirus SARS-CoV-2, known as COVID-19, has had a devastating impact on the global economy and healthcare systems, changing the definition of normal life. Developing effective therapeutics and preventive measures is crucial in fighting SARS-CoV-2 infection and restoring normalcy. Understanding COVID-19 pathogenesis is essential in guiding the development of anti-COVID-19 drugs and vaccines.

ARCHIVES OF PHARMACAL RESEARCH (2021)

添加到收藏夹

Article Virology

Defining IL-6 levels in healthy individuals: A meta-analysis

Elias A. Said et al.

Summary: This meta-analysis is the first to report IL-6 levels in the blood of healthy donors based on a large number of studies, with a pooled estimate of 5.186 pg/ml. Results showed that IL-6 values increased by 0.05 pg/ml for every 1 year increase in age. Despite heterogeneity, differences in IL-6 values were within a few pg/ml range, possibly due to varying conditions impacting IL-6 production in the healthy population.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Differential cytology profiles in bronchoalveolar lavage (BAL) in COVID-19 patients A descriptive observation and comparison with other corona viruses, Influenza virus, Haemophilus influenzae, and Pneumocystis jirovecii

Vanessa Vedder et al.

Summary: The study compared the cytological profiles of BALs from patients infected with various respiratory pathogens, finding that different pathogens caused distinct cell pattern changes but no general cell distribution pattern. Although the cytology pattern of BAL fluid is not specific enough to be used as the sole diagnostic criterion for COVID-19, it may support clinical decision-making.

MEDICINE (2021)

添加到收藏夹

Review Immunology

Immune reactivity during COVID-19: Implications for treatment

Claudio Napoli et al.

Summary: Clinical symptoms of COVID-19 include fever, cough, and fatigue, with severe cases often exhibiting lymphopenia and eosinopenia, leading to aberrant inflammatory response and cytokine storm. T cell response plays a critical role in understanding pathogenic mechanisms, with treatment strategies including corticosteroids and IL-6 receptor antagonists. Anticoagulative therapy and passive immunotherapy also show promise in reducing mortality and improving outcomes in COVID-19 patients.

IMMUNOLOGY LETTERS (2021)

添加到收藏夹

Article Virology

Characterization of T lymphocytes in severe COVID-19 patients

Daniela Fenoglio et al.

Summary: In severe COVID-19 patients, the expansion of circulating T cells may induce antibody response, inflammation, and regulation, potentially leading to a new form of biological target therapy.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Health Care Sciences & Services

Early Response of CD8+ T Cells in COVID-19 Patients

Deni Ramljak et al.

Summary: The study suggests that CD8+ T cells with higher perforin-1 and lower Fas ligand expression in the early stages of COVID-19 infection may be associated with progression to moderate and severe forms of the disease later on. Additionally, the frequency of effector memory CD8+ T cells was lower in all COVID-19 patients, and the mRNA expression of perforin-1 and interferon-gamma were significantly downregulated.

JOURNAL OF PERSONALIZED MEDICINE (2021)

添加到收藏夹

Review Immunology

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19

Mahda Delshad et al.

Summary: The outbreak of COVID-19 caused by SARS-CoV-2 has led to daunting complications worldwide. Increasing studies are shedding light on new features of the virus in hopes of finding proper treatment. Activation of antiviral immune responses by SARS-CoV-2 can lead to uncontrolled inflammation in severe cases, highlighting the importance of understanding lymphocyte dysfunction and guiding clinical management strategies.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Article Immunology

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Fan Wang et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

添加到收藏夹

Review Oncology

Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck

Tania Crombet Ramos et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

An aberrant STAT pathway is central to COVID-19

Toshifumi Matsuyama et al.

CELL DEATH AND DIFFERENTIATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

Sujin Kang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Immunology

B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients

Victor A. Sosa-Hernandez et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab

Armando Caballero et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

添加到收藏夹

Article Geriatrics & Gerontology

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra et al.

IMMUNITY & AGEING (2020)

添加到收藏夹

Article Oncology

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients

T Crombet et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.